C-reactive protein in intracerebral hemorrhage: Time course, tissue localization, and prognosis

Neurology

Volumn 79, Issue 7, 2012, Pages 690-699

  Di Napoli, Mario ^a,b   Godoy, Daniel Agustin ^c   Campi, Veronica ^c   Masotti, Luca ^d   Smith, Craig J ^e   Jones, Adrian R Parry ^e   Hopkins, Stephen J ^e   Slevin, Mark ^f,g   Papa, Francesca ^b   Mogoanta, Laurentiu ^h   Pirici, Daniel ^h   Wagner, Aurel Popa ^h,i  

^a SAN CAMILLO DE LELLIS HOSPITAL   (Italy)

^b SMDN   (Italy)

^c Neurocritical Care Unit Sanatorio Pasteur   (Argentina)

^d Cecina Hospital   (Italy)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

^f MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

^g HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^h UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

ⁱ Department of Psychiatry   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; ASTROCYTE; AUTOPSY; BLOOD VOLUME; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BRAIN TISSUE; CONTROLLED STUDY; FEMALE; GLASGOW OUTCOME SCALE; GLIA; HEMATOMA; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTICENTER STUDY; NERVE CELL; NEUROPATHOLOGY; NEURORADIOLOGY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN LOCALIZATION; RISK FACTOR; STROKE PATIENT; SURVIVAL;

EID: 84866056686     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318264e3be     Document Type: Article

References (29)

1. Aronowski J, Zhao X. Molecular pathophysiology of cerebral hemorrhage: secondary brain injury. Stroke 2011;42: 1781-1786.
2. Wang J. Preclinical and clinical research on inflammation after intracerebral hemorrhage. Prog Neurobiol 2010;92: 463-477.
3. Malham GM, Souter MJ. Systemic inflammatory response syndrome and acute neurological disease. Br J Neurosurg 2001;15:381-387.
4. Castellanos M, Leira R, Tejada J, Gil-Peralta A, Davalos A, Castillo J. Predictors of good outcome in medium to large spontaneous supratentorial intracerebral haemorrhages. J Neurol Neurosurg Psychiatry 2005;76:691- 695.
5. Di Napoli M, Godoy DA, Campi V, et al. C-reactive protein level measurement improves mortality prediction when added to the spontaneous intracerebral hemorrhage score. Stroke 2011;42:1230 -1236.
6. Diedler J, Sykora M, Hahn P, et al. C-reactive-protein levels associated with infection predict short- and longterm outcome after supratentorial intracerebral hemorrhage. Cerebrovasc Dis 2009;27:272-279.
7. Di Napoli M, Elkind MS, Godoy DA, Singh P, Papa F, Popa-Wagner A. Role of C-reactive protein in cerebrovascular disease: a critical review. Expert Rev Cardiovasc Ther 2011;9:1565-1584.
8. Teasdale G, Jennett B. Assessment of coma and impaired consciousness: a practical scale. Lancet 1974;2:81- 84.
9. Hemphill JC 3rd, Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 2001;32: 891-897.
10. Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Circulation 2007;116:e391- e413.
11. Steiner T, Kaste M, Forsting M, et al. Recommendations for the management of intracranial haemorrhage: part I: spontaneous intracerebral haemorrhage: The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee. Cerebrovasc Dis 2006;22:294 -316.
12. Roberts WL, Moulton L, Law TC, et al. Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2 Clin Chem 2001;47:418-425.
13. Kothari RU, Brott T, Broderick JP, et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke 1996;27:1304 -1305.
14. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage: a powerful and easy-to-use predictor of 30-day mortality. Stroke 1993;24: 987-993.
15. Ying SC, Gewurz H, Kinoshita CM, Potempa LA, Siegel JN. Identification and partial characterization of multiple native and neoantigenic epitopes of human C-reactive protein by using monoclonal antibodies. J Immunol 1989; 143:221-228.
16. Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet 1975;1:480-484.
17. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29 -36.
18. Silva Y, Leira R, Tejada J, Lainez JM, Castillo J, Davalos A. Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage. Stroke 2005;36: 86-91.
19. Kuhlmann CR, Librizzi L, Closhen D, et al. Mechanisms of C-reactive protein-induced blood-brain barrier disruption. Stroke 2009;40:1458 -1466.
20. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003;111:1805-1812.
21. Emsley HC, Smith CJ, Gavin CM, et al. An early and sustained peripheral inflammatory response in acute isch- aemic stroke: relationships with infection and atherosclerosis. J Neuroimmunol 2003;139:93-101.
22. Slevin M, Matou-Nasri S, Turu M, et al. Modified C-reactive protein is expressed by stroke neovessels and is a potent activator of angiogenesis in vitro. Brain Pathol 2010;20:151-165.
23. Eisenhardt SU, Thiele JR, Bannasch H, Stark GB, Peter K. C-reactive protein: how conformational changes influence inflammatory properties. Cell Cycle 2009;8: 3885-3892.
24. McGeer EG, Yasojima K, Schwab C, McGeer PL. The pentraxins: possible role in Alzheimer's disease and other innate inflammatory diseases. Neurobiol Aging 2001;22:843-848.
25. Strang F, Scheichl A, Chen YC, et al. Amyloid plaques dissociate pentameric to monomeric C-reactive protein: a novel pathomechanism driving cortical inflammation in Alzheimer's disease? Brain Pathol 2012;22:337-346.
26. Ji SR, Wu Y, Zhu L, et al. Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate: mCRP(m). FASEB J 2007;21:284 -294.
27. Eisenhardt SU, Habersberger J, Murphy A, et al. Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques. Circ Res 2009;105:128 -137.
28. Lauer N, Mihlan M, Hartmann A, et al. Complement regulation at necrotic cell lesions is impaired by the agerelated macular degeneration-associated factor-H His402 risk variant. J Immunol 2011;187:4374-4383.
29. Ji SR, Wu Y, Potempa LA, Liang YH, Zhao J. Effect of modified C-reactive protein on complement activation: a possible complement regulatory role of modified or monomeric C-reactive protein in atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2006;26:935-941.